» Articles » PMID: 23592585

How is a Metabolic Intermediate Formed in the Mechanism-based Inactivation of Cytochrome P450 by Using 1,1-dimethylhydrazine: Hydrogen Abstraction or Nitrogen Oxidation?

Overview
Journal Chemistry
Specialty Chemistry
Date 2013 Apr 18
PMID 23592585
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

A precise understanding of the mechanism-based inactivation of cytochrome P450 enzymes (P450s) at the quantum mechanical level should allow more reliable predictions of drug-drug interactions than those currently available. Hydrazines are among the molecules that act as mechanism-based inactivators to terminate the function of P450s, which are essential heme enzymes responsible for drug metabolism in the human body. Despite its importance, the mechanism explaining how a metabolic intermediate (MI) is formed from hydrazine is not fully understood. We used density functional theory (DFT) calculations to compare four possible mechanisms underlying the reaction between 1,1-dimethylhydrazine (or unsymmetrical dimethylhydrazine, UDMH) and the reactive compound I (Cpd I) intermediate of P450. Our DFT calculations provided a clear view on how an aminonitrene-type MI is formed from UDMH. In the most favorable pathway, hydrogen is spontaneously abstracted from the N2 atom of UDMH by Cpd I, followed by a second hydrogen abstraction from the N2 atom by Cpd II. Nitrogen oxidation of nitrogen atoms and hydrogen abstraction from the C-H bond of the methyl group were found to be less favorable than the hydrogen abstraction from the N-H bond. We also found that the reaction of protonated UDMH with Cpd I is rather sluggish. The aminonitrene-type MI binds to the ferric heme more strongly than a water molecule. This is consistent with the notion that the catalytic cycle of P450 is impeded when such an MI is produced through the P450-catalyzed reaction.

Citing Articles

CO reduction to CO on an iron-porphyrin complex with crown-ether appended cation-binding site.

Zhu C, Surendran A, DAgostino C, Roithova J, de Visser S Dalton Trans. 2025; .

PMID: 39996367 PMC: 11851269. DOI: 10.1039/d5dt00119f.


Melatonin Activation by Human Cytochrome P450 Enzymes: A Comparison between Different Isozymes.

Mokkawes T, De Visser T, Cao Y, de Visser S Molecules. 2023; 28(19).

PMID: 37836804 PMC: 10574541. DOI: 10.3390/molecules28196961.


Biotransformation of Bisphenol by Human Cytochrome P450 2C9 Enzymes: A Density Functional Theory Study.

Dias A, Yadav R, Mokkawes T, Kumar A, Skaf M, Sastri C Inorg Chem. 2023; 62(5):2244-2256.

PMID: 36651185 PMC: 9923688. DOI: 10.1021/acs.inorgchem.2c03984.


Mechanism of Melatonin Metabolism by CYP1A1: What Determines the Bifurcation Pathways of Hydroxylation versus Deformylation?.

Mokkawes T, Lim Z, de Visser S J Phys Chem B. 2022; 126(46):9591-9606.

PMID: 36380557 PMC: 9706573. DOI: 10.1021/acs.jpcb.2c07200.


Product Distributions of Cytochrome P450 OleT with Phenyl-Substituted Fatty Acids: A Computational Study.

Lin Y, de Visser S Int J Mol Sci. 2021; 22(13).

PMID: 34281222 PMC: 8269385. DOI: 10.3390/ijms22137172.